Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 11/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | SPR | P35270 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31250355 | 0.91 | GPR119 (0.49) | GPR119KDM4EIDO1CYP2C9 | |
| SCHEMBL25305154 | 0.91 | GPR119 (0.49) | GPR119KDM4EIDO1CYP2C9 | |
| SCHEMBL19946921 | 0.89 | GPR119 (0.49) | GPR119CYP2C9 | |
| SCHEMBL30527746 | 0.86 | GPR119 (0.54) | GPR119KDM4EIDO1SPRCYP2C9 | |
| SCHEMBL25262540 | 0.86 | GPR119 (0.54) | GPR119KDM4EIDO1SPRCYP2C9 | |
| SCHEMBL25888794 | 0.86 | GPR119 (0.62) | GPR119KDM4EIDO1SPR | |
| SCHEMBL25307728 | 0.84 | GPR119 (0.46) | GPR119KDM4EIDO1CYP2C9 | |
| SCHEMBL25306751 | 0.83 | GPR119 (0.52) | GPR119KDM4EIDO1 | |
| SCHEMBL31655197 | 0.82 | GPR119 (0.49) | GPR119KDM4EIDO1CYP2C9 | |
| SCHEMBL25309310 | 0.82 | GPR119 (0.47) | GPR119KDM4EIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024182447-A1 | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | VIVIDION THERAPEUTICS, INC. (US) | 2024-09-06 | — | — | WO | disclosed |